We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

114 hedge funds and large institutions have $510M invested in VanEck Pharmaceutical ETF in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

698% more call options, than puts

Call options by funds: $3.29M | Put options by funds: $412K

300% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 10

33% more funds holding

Funds holding: 86 → 114 (+28)

23% more capital invested

Capital invested by funds: $416M → $510M (+$94.3M)

10.69% more ownership

Funds ownership: 77.28% → 87.97% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

12% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 25

Holders
114
Holders Change
+28
Holders Change %
+32.56%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
40
Increased
22
Reduced
25
Closed
10
Calls
$3.29M
Puts
$412K
Net Calls
+$2.88M
Net Calls Change
-$4.11M

Top Buyers

Rank Fund Capital Flow
1
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$25.4M
2
Bank of America
Bank of America
North Carolina
+$15.9M
3
PCIA
Prime Capital Investment Advisors
Kansas
+$11.2M
4
VAS
Valicenti Advisory Services
New York
+$5.31M
5
AF
Alerus Financial
North Dakota
+$3.5M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$18.4M
2
NI
Noked Israel
Israel
-$9.41M
3
UBS Group
UBS Group
Switzerland
-$7.18M
4
TRCT
Tower Research Capital (TRC)
New York
-$3.48M
5
HF
HRT Financial
New York
-$3.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
IMC Chicago
26
IMC Chicago
Illinois
$1.81M -$97.7K -1,325 -5%
Vontobel Holding
27
Vontobel Holding
Switzerland
$1.79M +$221K +3,000 +15%
RJFSA
28
Raymond James Financial Services Advisors
Florida
$1.74M +$1.41M +19,106 +586%
Commonwealth Equity Services
29
Commonwealth Equity Services
Massachusetts
$1.61M +$346K +4,688 +29%
National Bank of Canada
30
National Bank of Canada
Quebec, Canada
$1.35M -$187K -2,533 -13%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$1.3M +$47.8K +648 +4%
Stifel Financial
32
Stifel Financial
Missouri
$1.23M -$1.14M -15,488 -49%
BHB
33
Bank Hapoalim BM
Israel
$1.16M +$127K +1,726 +13%
Marshall Wace
34
Marshall Wace
United Kingdom
$1.02M +$41.1K +557 +4%
AWM
35
Axxcess Wealth Management
California
$931K – – –
Cohen & Steers
36
Cohen & Steers
New York
$913K – – –
RFWA
37
RPg Family Wealth Advisory
Massachusetts
$870K +$13K +176 +2%
PPG
38
Peak Planning Group
Colorado
$793K +$221 +3 +0%
Osaic Holdings
39
Osaic Holdings
Arizona
$632K -$1.55K -21 -0.3%
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
$585K -$143K -1,942 -21%
CS
41
Credit Suisse
Switzerland
$567K +$538K +7,290 New
TWM
42
Tradition Wealth Management
Minnesota
$514K – – –
SWM
43
SeaCrest Wealth Management
New York
$497K +$112K +1,517 +31%
FTA
44
Financial & Tax Architects
Missouri
$410K +$384K +5,212 New
HF
45
HRT Financial
New York
$393K -$3.02M -40,941 -89%
Wells Fargo
46
Wells Fargo
California
$387K +$22.1K +300 +6%
RAM
47
Riggs Asset Management
Pennsylvania
$387K -$13.8K -187 -4%
Envestnet Asset Management
48
Envestnet Asset Management
Illinois
$375K +$58.3K +791 +20%
EH
49
Equitable Holdings
New York
$366K +$105K +1,420 +43%
CMI
50
Clare Market Investments
Texas
$364K +$346K +4,687 New
1
2
3 4 5

PPH Hedge Fund Activity: Q4 2022 in Review

114 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q4 2022, worth a combined $510M — up 23% from $416M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new PPH positions and 10 closed out — a net gain of 30 holders — while 22 added to existing stakes and 25 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $25.4M. The largest seller was Goldman Sachs, cutting an estimated $18.4M.

  • 114 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q4 2022, up from 86 in Q3 2022.
  • Funds reported $510M of VanEck Pharmaceutical ETF stock for Q4 2022, up 23% quarter-over-quarter.
  • 40 funds opened new VanEck Pharmaceutical ETF positions in Q4 2022 and 10 closed out, a net change of +30 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q4 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $25.4M added.
  • The largest VanEck Pharmaceutical ETF seller in Q4 2022 was Goldman Sachs, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2022.